Barbara S. Giesser, MD, FAAN, clinical director of the Multiple Sclerosis Program at UCLA, and a member of the Neurology Now editorial board, spoke with Stephanie Stephens about the different disease-modifying therapies for multiple sclerosis and how patients can treat and manage symptoms.